When Common Medications Trigger a Rare Reaction: A Review of Clinical Features, Diagnosis, and Treatment Options of DRESS Syndrome
DOI:
https://doi.org/10.12775/JEHS.2023.29.01.001Keywords
DRESS, drug reaction, eosinophilia, cutaneous reaction, hypersensitivityAbstract
Introduction and purpose: Drug-induced reaction with eosinophilia and systemic symptoms (DRESS) is a severe, life-threatening systemic drug reaction. The challenges in identifying DRESS syndrome result from its symptoms being variable, diverse, and unspecific. Due to the potentially lethal consequence, any clinician should be aware of the symptomatology and be prepared to initiate the appropriate steps. This review summarizes the clinical manifestations and provides essential information on the management of the illness.
State of knowledge: DRESS appears to be a rare reaction that frequently remains undetected due to its atypical clinical presentation. Fever, skin rash, lymphadenopathy, eosinophilia, and organ involvement as well as other manifestations, may occur. The onset may be delayed by weeks after exposure to the offending drug. DRESS syndrome is classified as a type IV hypersensitivity. It is thought to be triggered by antiepileptic drugs and antibiotics although many other medications can cause the condition. Certain genetic factors may also predispose some individuals to develop DRESS. Combining clinical and laboratory findings can help confirm the diagnosis. Discontinuation of the offending drug is the fundamental component of treatment such as supportive care including the use of antihistamines and corticosteroids, but recent research has discovered additional promising therapy options.
Conclusions: Detecting DRESS syndrome early is crucial to ensure prompt treatment, prevent serious complications, and improve patient outcomes. Healthcare providers should be aware of the signs and symptoms of DRESS syndrome, especially in patients taking particular medications, and be prepared to investigate further if it is suspected.
References
Avancini J, Maragno L, Santi CG, Criado PR. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: Clinical features of 27 patients Clin Exp Dermatol. 2015;40:851–9 doi: 10.1111/ced.12682
Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study. Neurology. 1997;49:542–6.
Alotaibi M. Drug-Induced Reaction With Eosinophilia and Systemic Symptoms: A Review. Cureus. 2023 Mar 2;15(3):e35701. doi: 10.7759/cureus.35701. PMID: 37012934; PMCID: PMC10066790.
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: A literature review. Am J Med. 2011;124(7):588-97.
Hiransuthikul A, Rattananupong T, Klaewsongkram J, Rerknimitr P, Pongprutthipan M, Ruxrungtham K. Druginduced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand. Allergol Int. 2016;65(4):432- 8.
Ramírez E, Medrano-Casique N, Tong HYHY, Bellón T, Cabañas R, Fiandor A, et al. Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospital. Br J Clin Pharmacol. 2017;83(2):400-15.
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module. Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. J Allergy Clin Immunol Pract. 2019;7:633–640.
Drug reactions with eosinophilia and systemic symptoms. Scrace B, Fityan A, Bigham C. BJA Educ. 2020;20:65–71.
Z. Husain, B. Y. Reddy, and R. A. Schwartz, “DRESS syndrome: Part I. Clinical perspectives,” Journal of the American Academy of Dermatology, vol. 68, no. 5, 2013.
Kardaun S.H., Sekula P., Valeyrie-Allanore L. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169:1071–1080.
Wang, Li; Mei, Xue-Ling. Drug Reaction with Eosinophilia and Systemic Symptoms: Retrospective Analysis of 104 Cases over One Decade. Chinese Medical Journal 130(8):p 943-949, April 20, 2017. | DOI: 10.4103/0366-6999.204104
G. Y. Kim, K. R. Anderson, D. M. R. Davis, J. L. Hand, and M. M. Tollefson, “Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: a systematic review of the literature,” Journal of the American Academy of Dermatology, vol. 83, no. 5, pp. 1323–1330, 2020.
F. Mori, C. Caffarelli, S. Caimmi et al., “Drug reaction with eosinophilia and systemic symptoms (DRESS) in children,” Acta BioMedica, vol. 90, no. 3, pp. 66–79, 2019.
Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;358(6): 568–579. 10.1056/NEJMoa0706135. Showed that HLA-B*5701 screening significantly reduced the risk of hypersensitivity reaction to abacavir.
Schunkert EM, Divito SJ. Updates and Insights in the Diagnosis and Management of DRESS Syndrome. Curr Dermatol Rep. 2021;10(4):192-204. doi: 10.1007/s13671-021-00348-z. Epub 2021 Nov 9. PMID: 34777921; PMCID: PMC8577395.
Seishima M., Yamanaka S., Fujisawa T., Tohyama M., Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br. J. Dermatol. 2006;155:344–349. doi: 10.1111/j.1365-2133.2006.07332.x.
Drago F., Cogorno L., Broccolo F., Ciccarese G., Parodi A. A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation. Osteoporos. Int. 2015;27:1261–1264. doi: 10.1007/s00198-015-3384-7.
Lee HY: Drug reaction with eosinophilia and systemic symptoms (DRESS). UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2023.
Cardones AR: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Clin Dermatol. 2020, 38:702-11. 10.1016/j.clindermatol.2020.06.008
G. Y. Kim, K. R. Anderson, D. M. R. Davis, J. L. Hand, and M. M. Tollefson, “Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: a systematic review of the literature,” Journal of the American Academy of Dermatology, vol. 83, no. 5, pp. 1323–1330, 2020.
Stirton H, Shear NH, Dodiuk-Gad RP. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS. Biomedicines. 2022 Apr 26;10(5):999. doi: 10.3390/biomedicines10050999. PMID: 35625735; PMCID: PMC9138571.
Cacoub P., Musette P., Descamps V., Meyer O., Speirs C., Finzi L., Roujeau J.C. The DRESS Syndrome: A Literature Review. Am. J. Med. 2011;124:588–597. doi: 10.1016/j.amjmed.2011.01.017.
Wolfson A.R., Zhou L., Li Y., Phadke N.A., Chow O.A., Blumenthal K.G. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module. J. Allergy Clin. Immunol. Pract. 2019;7:633–640. doi: 10.1016/j.jaip.2018.08.013.
Gouveia M.P., Gameiro A., Coutinho I., Pereira N., Cardoso J., Gonçalo M. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. Br. J. Dermatol. 2016;175:1274–1283. doi: 10.1111/bjd.14704.
Updates and Insights in the diagnosis and management of DRESS Syndrome. Schunkert EM, Divito SJ. Curr Dermatol Rep. 2021;10:192–204
Martínez-Cabriales S.A., Rodríguez-Bolaños F., Shear N.H. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come? Am. J. Clin. Dermatol. 2019;20:217–236. doi: 10.1007/s40257-018-00416-4.
Kardaun S.H., Sekula P., Valeyrie-Allanore L., Liss Y., Chu C.-Y., Creamer D., Sidoroff A., Naldi L., Mockenhaupt M., Roujeau J.C., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br. J. Dermatol. 2013;169:1071–1080. doi: 10.1111/bjd.12501
Gouveia M.P., Gameiro A., Coutinho I., Pereira N., Cardoso J., Gonçalo M. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. Br. J. Dermatol. 2016;175:1274–1283. doi: 10.1111/bjd.14704.
Chen Y.-C., Chiu H.-C., Chu C.-Y. Drug Reaction with Eosinophilia and Systemic Symptoms. Arch.Dermatol. 2010;146:1373–1379. doi: 10.1001/archdermatol.2010.198.
Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. Hama N, Abe R, Gibson A, Phillips EJ. J Allergy Clin Immunol Pract. 2022;10:1155–1167.
Cabañas R, Ramírez E, Sendagorta E, Alamar R, Barranco R, Blanca-López N, Doña I, Fernández J, Garcia-Nunez I, García-Samaniego J, Lopez-Rico R, Marín-Serrano E, Mérida C, Moya M, Ortega-Rodríguez NR, Rivas Becerra B, Rojas-Perez-Ezquerra P, Sánchez-González MJ, Vega-Cabrera C, Vila-Albelda C, Bellón T. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome. J Investig Allergol Clin Immunol. 2020;30(4):229-253. doi: 10.18176/jiaci.0480. Epub 2020 Jan 14. PMID: 31932268.
Lee JY, Seol YJ, Shin DW, Kim DY, Chun HW, Kim BY, et al A case of the drug reaction with eosinophilia and systemic symptom (DRESS) following isoniazid treatment Tuberc Respir Dis (Seoul). 2015;78:27–30 doi: 10.4046/trd.2015.78.1.27
Kardaun S.H., Sekula P., Valeyrie-Allanore L., Liss Y., Chu C.-Y., Creamer D., Sidoroff A., Naldi L., Mockenhaupt M., Roujeau J.C., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br. J. Dermatol. 2013;169:1071–1080. doi: 10.1111/bjd.12501.
Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia Int J Dermatol. 2010;49:834–41 doi: 10.1111/j.1365-4632.2010.04481.x
Kardaun S.H., Sekula P., Valeyrie-Allanore L., Liss Y., Chu C.-Y., Creamer D., Sidoroff A., Naldi L., Mockenhaupt M., Roujeau J.C., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br. J. Dermatol. 2013;169:1071–1080. doi: 10.1111/bjd.12501.
Severe acute hepatitis in drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome resolved following cyclosporine J Allergy Clin Immunol Pract (2020) Angie Ton, MD , Lena Kassab, MD, MBAb , Alicia Patel, PharmDc , and Nancy Dawson, MD
L. Metterle, L. Hatch, and L. Seminario-Vidal, “Pediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literature,” Pediatric Dermatology, vol. 37, no. 1, pp. 124–129, 2020.
E. Bedouelle, B. Ben Said, F. Tetart et al., “Drug reaction with eosinophilia and systemic symptoms (DRESS): series of 49 French pediatric cases,” Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 1, pp. 267–274.e5, 2022.
Kardaun S.H., Sekula P., Valeyrie-Allanore L., Liss Y., Chu C.-Y., Creamer D., Sidoroff A., Naldi L., Mockenhaupt M., Roujeau J.C., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br. J. Dermatol. 2013;169:1071–1080. doi: 10.1111/bjd.12501.
Chen Y.-C., Chiu H.-C., Chu C.-Y. Drug Reaction with Eosinophilia and Systemic Symptoms. Arch.Dermatol. 2010;146:1373–1379. doi: 10.1001/archdermatol.2010.198.
Shiohara T., Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol. Int. 2019;68:301–308. doi: 10.1016/j.alit.2019.03.006.
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019. Shiohara T, Mizukawa Y. Allergol Int. 2019;68:301–308.
Updates and Insights in the diagnosis and management of DRESS Syndrome. Schunkert EM, Divito SJ. Curr Dermatol Rep. 2021;10:192–204.
Drug reaction with eosinophilia and systemic symptoms (DReSS)/drug-induced hypersensitivity syndrome (DiHS)-readdressing the DReSS. Stirton H, Shear NH, Dodiuk-Gad RP. Biomedicines. 2022;10
Cabañas R, Ramírez E, Sendagorta E, Alamar R, Barranco R, Blanca-López N, Doña I, Fernández J, Garcia-Nunez I, García-Samaniego J, Lopez-Rico R, Marín-Serrano E, Mérida C, Moya M, Ortega-Rodríguez NR, Rivas Becerra B, Rojas-Perez-Ezquerra P, Sánchez-González MJ, Vega-Cabrera C, Vila-Albelda C, Bellón T. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome. J Investig Allergol Clin Immunol. 2020;30(4):229-253. doi: 10.18176/jiaci.0480. Epub 2020 Jan 14. PMID: 31932268.
Metterle L., Hatch L., Seminario-Vidal L. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature. Pediatr. Dermatol. 2019;37:124–129. doi: 10.1111/pde.14044.
Cabañas R, Ramírez E, Sendagorta E, Alamar R, Barranco R, Blanca-López N, Doña I, Fernández J, Garcia-Nunez I, García-Samaniego J, Lopez-Rico R, Marín-Serrano E, Mérida C, Moya M, Ortega-Rodríguez NR, Rivas Becerra B, Rojas-Perez-Ezquerra P, Sánchez-González MJ, Vega-Cabrera C, Vila-Albelda C, Bellón T. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome. J Investig Allergol Clin Immunol. 2020;30(4):229-253. doi: 10.18176/jiaci.0480. Epub 2020 Jan 14. PMID: 31932268.
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: A literature review. Am J Med. 2011;124(7):588-97.
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071-80.
Shiohara T., Inaoka M., Kano Y. Drug-Induced Hypersensitivity Syndrome (DIHS): A Reaction Induced by a Complex Interplay among Herpesviruses and Antiviral and Antidrug Immune Responses. Allergol. Int. 2006;55:1–8. doi: 10.2332/allergolint.55.1.
Lin I-CC, Yang H-CC, Strong C, Yang C-WW, Cho Y-TT, Chen K-LL, et al. Liver injury in patients with DRESS: A clinical study of 72 cases. J Am Acad Dermatol. 2015;72(6):984-91.
Shear N.H., Dodiuk-Gad R. In: Advances in Diagnosis and Management of Cu-Taneous Adverse Drug Reactions: Current and Future Trends. Shear N., Dodi-uk-Gad R., editors. Springer Nature Singapore Pte Ltd.; Singapore: 2019. pp. 87–104.
Kardaun S.H., Sekula P., Valeyrie-Allanore L., Liss Y., Chu C.-Y., Creamer D., Sidoroff A., Naldi L., Mockenhaupt M., Roujeau J.C., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br. J. Dermatol. 2013;169:1071–1080. doi: 10.1111/bjd.12501.
G. Y. Kim, K. R. Anderson, D. M. R. Davis, J. L. Hand, and M. M. Tollefson, “Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: a systematic review of the literature,” Journal of the American Academy of Dermatology, vol. 83, no. 5, pp. 1323–1330, 2020.
Kano Y., Ishida T., Hirahara K., Shiohara T. Visceral Involvements and Long-term Sequelae in Drug-induced Hypersensitivity Syndrome. Med. Clin. N. Am. 2010;94:743–759. doi: 10.1016/j.mcna.2010.03.004.
P. T. Taweesedt, C. W. Nordstrom, J. Stoeckel, and I. Dumic, “Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review,” BioMed Research International, vol. 2019, Article ID 7863815, 10 pages, 2019.
Eshki M., Allanore L., Musette P., Milpied B., Grange A., Guillaume J.-C., Chosidow O., Guillot I., Paradis V., Joly P., et al. Twelve-Year Analysis of Severe Cases of Drug Reaction with Eosinophilia and Systemic Symptoms. Arch. Dermatol. 2009;145:67–72. doi: 10.1001/archderm.145.1.67.
Thongsri T, Chularojanamontri L, Pichler WJ. Cardiac involvement in DRESS syndrome. Asian Pac J Allergy Immunol. 2017 Mar;35(1):3-10. doi: 10.12932/AP0847. PMID: 27996289.
Radovanovic M., Jevtic D., Calvin A.D., Petrovic M., Paulson M., Prada L.R., Sprecher L., Savic I., Dumic I. “Heart in DRESS&rdquo: Cardiac Manifestations, Treatment and Outcome of Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Systematic Review. J. Clin. Med. 2022;11:704. doi: 10.3390/jcm11030704.
Kardaun S.H., Sekula P., Valeyrie-Allanore L., Liss Y., Chu C.-Y., Creamer D., Sidoroff A., Naldi L., Mockenhaupt M., Roujeau J.C., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br. J. Dermatol. 2013;169:1071–1080. doi: 10.1111/bjd.12501.
Cacoub P., Musette P., Descamps V., Meyer O., Speirs C., Finzi L., Roujeau J.C. The DRESS Syndrome: A Literature Review. Am. J. Med. 2011;124:588–597. doi: 10.1016/j.amjmed.2011.01.017.
Kano Y., Ishida T., Hirahara K., Shiohara T. Visceral Involvements and Long-term Sequelae in Drug-induced Hypersensitivity Syndrome. Med. Clin. N. Am. 2010;94:743–759. doi: 10.1016/j.mcna.2010.03.004.
Chen Y-C, Chiu H-C, Chu C-Y. Drug Reaction With Eosinophilia and Systemic Symptoms. Arch Dermatol. 2010;146(12):1373.
Chen Y-C, Chiu H-C, Chu C-Y. Drug Reaction With Eosinophilia and Systemic Symptoms. Arch Dermatol. 2010;146(12):1373.
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071-80.
Chen Y-C, Chang C-Y, Cho Y-T, et al. 2013. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. Journal of the American Academy of Dermatology 68(3): 459–65. DOI: http://dx.doi.org/10.1016/j.jaad.2012.08.009 (accessed 14 July 2020).
Kano Y, Tohyama M, Aihara M, et al. 2015. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). Journal of Dermatology 42: 276–82. DOI: 10.1111/1346-8138.12770 (accessed 14 July 2020)
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: A literature review. Am J Med. 2011;124(7):588-97.
Kardaun S., Sidoroff A., Valeyrie-Allanore L., Halevy S., Davidovici B., Mockenhaupt M., Roujeau J. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br. J. Dermatol. 2007; 156:609–611. doi: 10.1111/j.1365-2133.2006.07704. x.
Stirton H, Shear NH, Dodiuk-Gad RP. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS. Biomedicines. 2022 Apr 26;10(5):999. doi: 10.3390/biomedicines10050999. PMID: 35625735; PMCID: PMC9138571.
Sasidharanpillai S, Ajithkumar K, Jishna P, Khader A, Anagha KV, Binitha MP, Chathoth AT. RegiSCAR DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) Validation Scoring System and Japanese Consensus Group Criteria for Atypical Drug-Induced Hypersensitivity Syndrome (DiHS): A Comparative Analysis. Indian Dermatol Online J. 2022 Jan 24;13(1):40-45. doi: 10.4103/idoj.idoj_196_21. PMID: 35198466; PMCID: PMC8809161.
Shiohara T, Kano Y. DRESS syndrome (drug reaction with eosinophilia and systemic symptoms): update in 2019. Allergol Int. 2019 Oct;68(4):301-308. doi: 10.1016/j.alit.2019.07.004.
Cabañas R., Ramírez E., Sendagorta E., Alamar R., Barranco R., Blanca-López N., Doña I., Fernández J., Garcia-Nunez I., García-Samaniego J., et al. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome. J. Investig. Allergy Clin. Immunol. 2020; 30:229–253. doi: 10.18176/jiaci.0480.
Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007 Apr;156(4):609-11. doi: 10.1111/j.1365-2133.2006.07643. x.
Ahmed Abushahin, Haneen Toma, Sara G. Hamad, Mutasim Abu-Hasan, "Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Child with Cystic Fibrosis", Case Reports in Immunology, vol. 2023, Article ID 1006376, 6 pages, 2023. https://doi.org/10.1155/2023/1006376
Cabañas R, Ramírez E, Sendagorta E, Alamar R, Barranco R, Blanca-López N, Doña I, Fernández J, Garcia-Nunez I, García-Samaniego J, Lopez-Rico R, Marín-Serrano E, Mérida C, Moya M, Ortega-Rodríguez NR, Rivas Becerra B, Rojas-Perez-Ezquerra P, Sánchez-González MJ, Vega-Cabrera C, Vila-Albelda C, Bellón T. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome. J Investig Allergol Clin Immunol. 2020;30(4):229-253. doi: 10.18176/jiaci.0480. Epub 2020 Jan 14. PMID: 31932268.
Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. J Am Acad Dermatol. 2013 Feb;68(2):e1-14. doi: 10.1016/j.jaad.2012.06.045.
Ahmed Abushahin, Haneen Toma, Sara G. Hamad, Mutasim Abu-Hasan, "Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in a Child with Cystic Fibrosis", Case Reports in Immunology, vol. 2023, Article ID 1006376, 6 pages, 2023. https://doi.org/10.1155/2023/1006376
Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. J Am Acad Dermatol. (2013) 68:709–32. doi: 10.1016/j.jaad.2013.01.032
Verstegen RHJ, Phillips EJ and Juurlink DN (2023) First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroids. Front. Med. 10:1138464. doi: 10.3389/fmed.2023.1138464
Hama N, Abe R, Gibson A, Phillips EJ. Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. J Allergy Clin Immunol Pract. (2022) 10:1155–67. doi: 10.1016/j.jaip.2022.02.004
Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. J Am Acad Dermatol. (2013) 68:709–32. doi: 10.1016/j.jaad.2013.01.032
Verstegen RHJ, Phillips EJ and Juurlink DN (2023) First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroids. Front. Med. 10:1138464. doi: 10.3389/fmed.2023.1138464
Descamps V., ben Saïd B., Sassolas B., Truchetet F., Avenel-Audran M., Girardin P., Guinnepain M.T., Mathelier-Fusade P., Assier H., Milpied B., et al. Management of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Ann. Dermatol. Venereol. 2010;137:703–708. doi: 10.1016/j.annder.2010.04.024.
Stirton H, Shear NH, Dodiuk-Gad RP. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS. Biomedicines. 2022 Apr 26;10(5):999. doi: 10.3390/biomedicines10050999. PMID: 35625735; PMCID: PMC9138571.
Scrace B, Fityan A, Bigham C. Drug reactions with eosinophilia and systemic symptoms. BJA Educ. 2020 Feb;20(2):65-71. doi: 10.1016/j.bjae.2019.11.001. Epub 2020 Jan 8. PMID: 33456932; PMCID: PMC7808006.
Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a drug-induced hypersensitivity syndrome with variable clinical features. J Dermatol. 2011 Jun;38(6):506-11. doi: 10.1111/j.1346-8138.2010.01159.x.
Heelan K., Shear N.H. Cutaneous Drug Reactions in Children: An Update. Pediatr. Drugs. 2013;15:493–503. doi: 10.1007/s40272-013-0039-z.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Aleksandra Hajduk, Łukasz Mrozek, Konrad Klocek, Bartosz Kostecki, Aleksander Jurek, Maciej Zwolski, Zuzanna Szumlas, Krzysztof Puchalski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 384
Number of citations: 0
